Although our case demonstrated no significant evidence of benefit from immunotherapy, studies have shown that more than 65% of such tumors exhibit high PD-L1 expression in both tumor cells and immune cells within the tumor microenvironment (32, 33). Here, CD274 is linked to neoplasm.